Literature DB >> 35399166

Transabdominal Ultrasonography for Preoperative Diagnosis of Lymph Node Metastasis in Colon Cancer: A Retrospective Cohort Study.

Ken Imaizumi1, Shigenori Homma1, Mutsumi Nishida2, Takeshi Soyama3, Ryosuke Shimura3, Yusuke Kudo2, Satomi Omotehara2, Isao Yokota4, Ryo Takagi4, Hiroki Matsui1, Yoichi Miyaoka1, Nobuki Ichikawa1, Tadashi Yoshida1, Norihiko Takahashi1, Akinobu Taketomi1.   

Abstract

Background/Aim: Although computed tomography (CT) is the standard modality for diagnosing lymph node metastasis (LNM), transabdominal ultrasonography (US) can be useful due to its high spatial resolution and use of Doppler signals to precisely analyse lymph nodes. This study aimed to evaluate the accuracy of US for lymph node assessment, establish US-based diagnostic criteria for LNM, and compare the capability of US with that of CT for the diagnosis of LNM. Patients and
Methods: This retrospective, single-institution, cohort study included patients who underwent radical surgery for clinical stage 0-III colon cancer, between March 2012 and February 2019.
Results: Overall, 34.9% (66/189) of patients had pathological LNM. The optimal US diagnostic criteria were 1) short axis ≥7 mm and short/long ratio ≥0.75 and 2) at least two of the following: the absence of hilar echoes, expansive appearance, or peripheral/mixed vascularity by the colour Doppler and/or contrast-enhanced method. Compared to CT, US showed a higher diagnostic sensitivity (54.5% vs. 43.9%; p=0.296), higher concordance with the number of pathological LNM (correlation coefficient: US, 0.42; CT, 0.27) and pathological N diagnosis (weighted ĸ: US, 0.35; CT, 0.18), and higher sensitivity for advanced LNM, including multiple LNMs (47.4% vs. 18.4%; p=0.014) and N2 stage (27.8% vs. 5.6%; p=0.177).
Conclusion: US has higher sensitivity than CT for diagnosing LNM in colon cancer, along with a more accurate preoperative diagnosis of the N stage. Additionally, US may be more helpful than CT alone for preoperatively deciding the appropriateness of neoadjuvant treatment in colon cancer with advanced LNM. Copyright 2022, International Institute of Anticancer Research.

Entities:  

Keywords:  Transabdominal ultrasonography; colon cancer; computed tomography; contrast-enhanced ultrasonography; lymph node metastasis

Year:  2022        PMID: 35399166      PMCID: PMC8962819          DOI: 10.21873/cdp.10092

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  38 in total

1.  Use of transabdominal ultrasonography to preoperatively determine T-stage of proven colon cancers.

Authors:  Susumu Shibasaki; Norihiko Takahashi; Shigenori Homma; Mutsumi Nishida; Tatsushi Shimokuni; Tadashi Yoshida; Hideki Kawamura; Noriko Oyama-Manabe; Kohsuke Kudo; Akinobu Taketomi
Journal:  Abdom Imaging       Date:  2015-08

2.  Preoperative evaluation of local invasion and metastatic lymph nodes of colorectal cancer and mesenteric vascular variations using multidetector-row computed tomography before laparoscopic surgery.

Authors:  Takaaki Kanamoto; Mitsuru Matsuki; Junji Okuda; Yuki Inada; Fuminari Tatsugami; Masato Tanikake; Shushi Yoshikawa; Isamu Narabayashi; Hiroshi Kawasaki; Keitaro Tanaka; Tetsuhisa Yamamoto; Nobuhiko Tanigawa; Yutaro Egashira; Yuro Shibayama
Journal:  J Comput Assist Tomogr       Date:  2007 Nov-Dec       Impact factor: 1.826

3.  Hidrocolonic ultrasonography in the detection of tumoral processes in the inferior gastrointestinal tract.

Authors:  J M Segura; E Molina; A Herrera; M A Berges; J C Erdozain; A Arjonilla; J M Suárez; M González Barón
Journal:  Rev Esp Enferm Dig       Date:  1998-11       Impact factor: 2.086

4.  Preoperative staging of colorectal cancer: accuracy of single portal venous phase multidetector computed tomography.

Authors:  Derya Tezcan; Aysel Türkvatan; Mehmet Akif Türkoğlu; Erdal Birol Bostancı; Zişan Sakaoğullları
Journal:  Clin Imaging       Date:  2013-09-20       Impact factor: 1.605

5.  TNM staging of gastrointestinal tumors by hydrosonography: results of a histopathologically controlled study in 60 patients.

Authors:  M Düx; T Roeren; C Kuntz; G M Richter; G W Kauffmann
Journal:  Abdom Imaging       Date:  1997 Jan-Feb

Review 6.  Overview of preoperative and postoperative therapy for colorectal cancer: the European and United States perspectives.

Authors:  Ian Chau; Samuel Chan; David Cunningham
Journal:  Clin Colorectal Cancer       Date:  2003-05       Impact factor: 4.481

7.  Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer.

Authors:  Michael Hocke; Ewald Schulze; Peter Gottschalk; Theodor Topalidis; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

8.  Endosonographic features predictive of lymph node metastasis.

Authors:  M F Catalano; M V Sivak; T Rice; L A Gragg; J Van Dam
Journal:  Gastrointest Endosc       Date:  1994 Jul-Aug       Impact factor: 9.427

9.  Colorectal carcinomas: diagnosis and preoperative staging by hydrocolonic sonography.

Authors:  C R Hernández-Socorro; C Guerra; J Hernández-Romero; A Rey; P López-Facal; V Alvarez-Santullano
Journal:  Surgery       Date:  1995-06       Impact factor: 3.982

10.  Optimal diagnostic method using multidetector-row computed tomography for predicting lymph node metastasis in colorectal cancer.

Authors:  Tsutomu Kumamoto; Junichi Shindoh; Hideaki Mita; Yuriko Fujii; Yuichiro Mihara; Michiro Takahashi; Nobuyuki Takemura; Takako Shirakawa; Hisashi Shinohara; Hiroya Kuroyanagi
Journal:  World J Surg Oncol       Date:  2019-02-22       Impact factor: 2.754

View more
  2 in total

1.  A perforated sigmoid colon cancer initially diagnosed as a tubo-ovarian abscess: A teaching case.

Authors:  Asieh Maleki; Parvaneh Layegh; Seyedeh Hoda Seddighian; Maedeh Khosravi; Mona Ariamanesh; Mansoureh Dehghani
Journal:  Clin Case Rep       Date:  2022-06-26

2.  Value of MSCT plus MRI in the Detection of Colon Cancer.

Authors:  Jingni Zhang; Yu Bao
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-31       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.